Target Group Inc.
CBDYDrugs in Pipeline
9
Phase 3 Programs
3
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
OTL38 for Injection
Lung Neoplasms
NRX-101
Bipolar Depression
OTL38
Ovarian Cancer
NRX-101 Oral Capsule
Bipolar Depression
0.03mg/kg ZOPOCIANINE given day of surgery
Prostate Cancer Surgery
Ha44 Gel
Head Lice Infestation
One POMx capsule daily
Erectile Dysfunction
Cytalux™ (pafolacianine) for fluorescent imaging
Prostate Cancer
CYTALUX™ (pafolacianine) injection preoperatively
Esophageal Cancer
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
OTL38 for Injection | Phase 3 | Lung Neoplasms | - | - |
NRX-101 | Phase 3 | Bipolar Depression | - | - |
OTL38 | Phase 3 | Ovarian Cancer | - | - |
NRX-101 Oral Capsule | Phase 2 | Bipolar Depression | - | - |
0.03mg/kg ZOPOCIANINE given day of surgery | Phase 2 | Prostate Cancer Surgery | - | - |
Ha44 Gel | Phase 2 | Head Lice Infestation | - | - |
One POMx capsule daily | Phase 2 | Erectile Dysfunction | - | - |
Cytalux™ (pafolacianine) for fluorescent imaging | Phase 2 | Prostate Cancer | - | - |
CYTALUX™ (pafolacianine) injection preoperatively | Phase 2 | Esophageal Cancer | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Target Group Inc.'s drug pipeline?→
CatalystAlert tracks 9 drug candidates in Target Group Inc.'s (CBDY) pipeline across Phase 3, Phase 2. Its lead program is OTL38 for Injection (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Target Group Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Target Group Inc. (CBDY) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track CBDY biotech catalysts?→
Add CBDY to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Target Group Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.